Glenmark initiates IND enabling studies of novel monoclonal antibody targeting OX40
GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.